A Study of Pegylated Interferon Alfa-2a and Lamivudine in Patients With HBeAg-Negative Chronic Hepatitis B Virus (HBV)
Clinical trial NCT01095835 · COMPLETED
Trial details
- NCT number
- NCT01095835
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-02-01
- Primary completion
- 2010-01-01
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.